A Phase 3 Randomized, Active-Controlled, Double-Masked Study to Evaluate the Safety and Efficacy of TRS01 Eye Drops in the Treatment of Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

摘要

2021 SEP 27 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Staff editors report on the newly launched clinical trial, NCT05042609, which has the following summary description: "The primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma"